Hill Joins Group of State’s Leading Experts to Promote, Accelerate Digital Health Innovation in Massachusetts
BOSTON, Mass. – November 22, 2016 – Today Colin Hill, the Chairman, CEO and co-founder of leading precision medicine company GNS Healthcare (GNS), was appointed by Massachusetts Gov. Charlie Baker to the newly formed Massachusetts Digital Health Council. The Council, also announced today by Gov. Baker, will advise the Governor on the digital health industry and work to achieve the goal of creating the leading global ecosystem for digital health in Massachusetts.
“For Massachusetts to become a national leader in digital health, we need to continue to build on the momentum our Digital Health Initiative has already produced,” said Gov. Baker. “This council will collaborate to move past barriers in the healthcare industry and solve significant challenges to make advances in patient care, lower health care costs, and address public health crises…”
The Council, composed of 38 leading life science and healthcare authorities in Massachusetts, is first tasked with delivering a three-year growth plan to the Governor by August 2017. The plan will lay out the Council’s recommendations and establish objectives for the state’s promotion and acceleration of digital healthcare innovation across the Commonwealth. The Council will also implement its plan and will report annually on its activities and progress.
“Massachusetts is already highly respected around the globe as a magnet for life science and healthcare innovation,” said Hill. “It is an incredible honor to be appointed by the Governor to help the state leverage its substantial existing resources to establish Massachusetts as the leading destination in the world for digital health investment and growth, a goal that promises to improve the quality of care for individuals in the state while reducing overall costs.”
About GNS Healthcare
GNS Healthcare solves healthcare’s matching problem for leading health plans, biopharma companies, and health systems. We transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals, improving health outcomes and saving billions of dollars. Our causal learning and simulation platform, REFS, accelerates the discovery of what works for whom and why.